Peter Smith
Company: United Therapeutics Corp.
Job title: Vice President Product Development
Seminars:
Analyzing Design of a Phase 3 Trial for Inhaled Treprostinil 5:00 pm
• Exploring the scientific rationale behind inhaled Treprostinil • Phase 3 trial design and special considerations of inhaled candidate for evaluating the long-term safety and tolerability of TreprostinilRead more
day: Day One